Carrera Capital Advisors Acquires 6,743 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Carrera Capital Advisors raised its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 42.5% in the fourth quarter, Holdings Channel reports. The firm owned 22,611 shares of the company’s stock after purchasing an additional 6,743 shares during the period. Carrera Capital Advisors’ holdings in HealthEquity were worth $2,170,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Arcadia Investment Management Corp MI bought a new position in HealthEquity during the fourth quarter valued at about $26,000. Smartleaf Asset Management LLC boosted its stake in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after acquiring an additional 98 shares during the last quarter. Proficio Capital Partners LLC bought a new position in shares of HealthEquity during the 4th quarter valued at approximately $39,000. UMB Bank n.a. increased its stake in shares of HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after purchasing an additional 164 shares during the last quarter. Finally, First Horizon Advisors Inc. lifted its stake in HealthEquity by 50.7% in the fourth quarter. First Horizon Advisors Inc. now owns 1,115 shares of the company’s stock valued at $107,000 after purchasing an additional 375 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the transaction, the director now directly owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the completion of the sale, the director now owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 39,000 shares of company stock valued at $3,895,788 in the last quarter. Insiders own 2.20% of the company’s stock.

Wall Street Analyst Weigh In

HQY has been the topic of a number of recent research reports. Barrington Research upped their price target on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Monday, December 2nd. Raymond James upped their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Tuesday, February 25th. The Goldman Sachs Group started coverage on shares of HealthEquity in a research report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target on the stock. JMP Securities raised their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. Finally, Wells Fargo & Company boosted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $113.54.

HealthEquity Price Performance

NASDAQ:HQY opened at $102.99 on Wednesday. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The stock has a fifty day moving average of $105.33 and a 200 day moving average of $93.89. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The firm has a market capitalization of $8.93 billion, a price-to-earnings ratio of 94.49, a P/E/G ratio of 1.60 and a beta of 0.55.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the company posted $0.40 EPS. On average, research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.